Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Gasparetto

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|March 17, 2004
Stem cell transplantation for multiple myelomaCristina Gasparetto
Cancer Medicine|May 16, 2018
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocationPasupathi Sundaramoorthy, Cristina Gasparetto, Yubin Kang
Future Oncology (London, England)|October 26, 2016
Panobinostat for the management of multiple myelomaDharshan Sivaraj, Michael M Green, Cristina Gasparetto
Case Reports in Hematology|September 1, 2012
Lenalidomide-Associated ITPChristina I Herold, Cristina Gasparetto, Gowthami M Arepally
Case Reports in Hematology|December 24, 2025
Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With VenetoclaxAllison O Taylor, Stephanie Clune, JoAnn Liu, et al.
Frontiers in Oncology|October 8, 2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacyMuhamed Baljevic, Gary Schiller, Tomer M Mark, et al.
Oncology and Therapy|March 7, 2017
Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple MyelomaRachid C Baz, Jeffrey A Zonder, Cristina Gasparetto, et al.
Asploro Journal of Biomedical and Clinical Case Reports|February 28, 2022
Anaplastic Multiple Myeloma: Case Series and Literature ReviewJian Wu, Emily Chu, Cristiana Costa Chase, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2017
Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple MyelomaPeter M Voorhees, Cristina Gasparetto, Dominic T Moore, et al.
Journal of Hematology & Oncology|February 28, 2018
Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myelomaZhihong Zheng, Shengjun Fan, Jing Zheng, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Cancer Control : Journal of the Moffitt Cancer Center|March 17, 2004
Stem cell transplantation for multiple myelomaCristina Gasparetto
Cancer Medicine|May 16, 2018
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocationPasupathi Sundaramoorthy, Cristina Gasparetto, Yubin Kang
Future Oncology (London, England)|October 26, 2016
Panobinostat for the management of multiple myelomaDharshan Sivaraj, Michael M Green, Cristina Gasparetto
Case Reports in Hematology|September 1, 2012
Lenalidomide-Associated ITPChristina I Herold, Cristina Gasparetto, Gowthami M Arepally
Case Reports in Hematology|December 24, 2025
Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With VenetoclaxAllison O Taylor, Stephanie Clune, JoAnn Liu, et al.
Frontiers in Oncology|October 8, 2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacyMuhamed Baljevic, Gary Schiller, Tomer M Mark, et al.
Oncology and Therapy|March 7, 2017
Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple MyelomaRachid C Baz, Jeffrey A Zonder, Cristina Gasparetto, et al.
Asploro Journal of Biomedical and Clinical Case Reports|February 28, 2022
Anaplastic Multiple Myeloma: Case Series and Literature ReviewJian Wu, Emily Chu, Cristiana Costa Chase, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2017
Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple MyelomaPeter M Voorhees, Cristina Gasparetto, Dominic T Moore, et al.
Journal of Hematology & Oncology|February 28, 2018
Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myelomaZhihong Zheng, Shengjun Fan, Jing Zheng, et al.
Pageof 10